glp-1 obesity drug news today 2025-10-20 Market US adult obesity rate drops

Contact Acreaty today and take the first step toward smarter business solutions

The tension between semaglutides and body acceptance is palpable

Evolution of gestational diabetes mellitus across continents in 21st century

Her studies have transformed our understanding of peptide hormones and laid the foundation for life-changing therapies for type 2 diabetes and obesity, said Ali Shilatifard, the chair and Robert Francis Furchgott Professor of Biochemistry and Molecular Genetics, and director of the Simpson Querrey Institute for Epigenetics, which awards the annual Kimberly Prize

The Story The last time we wrote about affordable diabetes and weight-loss drugs, about a year ago, we told you that a drug revolution would arrive in 2026

Compared to TrimRx ($149/month) and MEDVi (~$179/month) , Willow is notably more expensive